Epocrates EHR Receives ONC-ATCB Certification by Drummond Group
February 03 2012 - 2:20PM
Epocrates, Inc. (Nasdaq:EPOC) has received the federal government's
"meaningful use" stamp of approval by earning complete EHR
ambulatory certification for Epocrates EHR v2. The designation
officially deems the electronic health record (EHR) software
capable of enabling providers to qualify for funding under the
American Recovery and Reinvestment Act (ARRA). Tested and certified
under the Drummond Group's Electronic Health Records Office of the
National Coordinator Authorized Testing and Certification Body
(ONC-ATCB) program, the EHR software is 2011/2012 compliant in
accordance with the criteria adopted by the Secretary of Health and
Human Services.
"Certification is an important step towards availability of the
complete Epocrates EHR solution for small physician practices
seeking a simple and adaptable system," said Dr. Tom Giannulli,
chief medical information officer of Epocrates. "Epocrates EHR is
designed to work the way physicians work with optimized versions
for online, iPhone and, coming soon, the iPad. Between
certification and our flexible solution, we are positioning our
physicians to earn maximum incentives in 2012 and beyond by
demonstrating meaningful use with their patients in a meaningful
way."
Drummond Group's ONC-ATCB 2011/2012 certification program tests
and certifies that EHRs meet the meaningful use criteria for either
eligible provider or hospital technology. In turn, healthcare
providers using the EHR systems of certified vendors are qualified
to receive federal stimulus monies upon demonstrating meaningful
use of the technology – a key component of the federal government's
push to improve clinical care delivery through the adoption and
effective use of EHRs by U.S. healthcare providers.
The Epocrates EHR is a secure, web-based SaaS system designed to
meet the distinct needs of small physician practices with a
user-friendly interface, affordable cost structure, and
comprehensive support and service program. It features core EHR
capabilities, including patient encounter notes, electronic lab
integration, ePrescribing, and Epocrates' market-leading drug
content formatted in harmony with physicians' natural workflow. In
accordance with meaningful use criteria, the solution now also
includes a patient portal, templates and clinical decision
support.
"The need to leverage information technology in the healthcare
industry is huge – as the quality of care and efficiency benefits
that come with computerization can really make a difference in the
overall patient experience," says Rik Drummond, chief executive
officer of the Drummond Group.
Epocrates EHR v2 is 2011/2012 compliant and has
been certified as a Complete EHR by Drummond Group Inc.,
an ONC-ATCB, in accordance with the applicable certification
criteria adopted by the Secretary of Health and Human Services.
This certification does not represent an endorsement by the U.S.
Department of Health and Human Services or guarantee the receipt of
incentive payments. The ONC certification number is
02022012-1326-8 and was granted on February 2, 2012. The
clinical quality measures to which Epocrates EHR v2 has been
certified include: NQF0013, NQF0018, NQF0024, NQF0028,
NQF0038, NQF0041, NQF0043, NQF0061, NQF0421. The additional
software that Epocrates EHR v2 relied upon to demonstrate
compliance includes: AHRQ ePSS, LabSoft, Healthwise, OpenSSL,
popHealth.
About Drummond Group
Drummond Group Inc., the trusted software test lab, provides
effective and efficient electronic health record (EHR) testing to
healthcare information technology vendors and hospitals. As an
Office of the National Coordinator Authorized Testing and
Certification Body (ONC-ATCB), Drummond Group works closely with
healthcare software vendors and hospitals to certify EHRs that are
looking to qualify for incentive funds under the American Recovery
and Reinvestment Act (ARRA). Drummond Group is approved to
certify both complete and modular EHR for both ambulatory and
inpatient. Leveraging more than a decade's worth of
interoperability, conformance testing and certification experience
in multiple industries, Drummond Group delivers what's needed in
healthcare: highly reliable and readily affordable software testing
services. For more information, go to www.drummondgroup.com.
About Epocrates, Inc.
Epocrates, Inc. (Nasdaq:EPOC) is a leading physician platform
for essential clinical content, practice tools and health industry
engagement at the point of care. The Epocrates network consists of
more than 1.4 million healthcare professionals, including 50
percent of U.S. physicians, who routinely use its solutions and
services. Epocrates' portfolio includes top-ranked medical apps,
such as the industry's #1 most used mobile drug reference, valuable
manufacturer resources, and a SaaS web-based electronic health
record. Through these intuitive and reliable resources, the company
supports clinical decisions, helps improve physician workflow and
impacts patient outcomes. For more information, please visit
www.epocrates.com/company.
The Epocrates, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=11331
Epocrates is a trademark of Epocrates, Inc., registered in the
U.S. and other countries.
Forward-Looking Statements
The statements in this press release relating to future
developments, enhancements and expansion of Epocrates EHR
offerings, are forward-looking statements. These forward-looking
statements are based upon the company's current expectations.
Actual results could differ materially from these forward-looking
statements as a result of certain factors, including: unanticipated
defects in the EHR offering may be discovered which could cause a
delay in further development or certification; as well as those
other risks detailed in Epocrates' filings with the Securities and
Exchange Commission (SEC), including in its Annual Report on Form
10-K filed with the SEC on March 31, 2011. Readers are cautioned
not to place undue reliance on these forward-looking statements,
which speak only as of the date of this press release. Epocrates
does not undertake any obligation to update any forward-looking
statements as a result of new information, future events, changed
assumptions or otherwise.
CONTACT: Erica Sniad Morgenstern
Senior Director, Public Relations and Communication
Epocrates, Inc.
(650) 227-6907
pr@epocrates.com
Epocrates, Inc. (MM) (NASDAQ:EPOC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Epocrates, Inc. (MM) (NASDAQ:EPOC)
Historical Stock Chart
From Jul 2023 to Jul 2024